Mesoblast Successfully Completes Placement and Accelerated
NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
Read moreNEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
Read moreHEALWELL has completed the previously announced acquisition of Intrahealth, a SaaS based enterprise class multi-national EHR (Electronic Health Record) provider ...
Read moreSALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and ...
Read moreAutonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic ...
Read moreThe AMM Foundation, the Corporate Social Responsibility (CSR) arm of the Murugappa Group, marked a historic milestone on Monday ...
Read moreThe trial now progresses into its second part, expected to complete later in 2024. ALK to submit a protocol amendment ...
Read moreAppointment of Marco Bedoya, a proven leader in medical device mechanical engineering, as Director of Product Development Engagements secured with ...
Read morePatented two-fold technology in development to locate, ablate and confirm successful ablation of specific nerves for pain management and other ...
Read moreCompany announcement – No. 3 / 2024 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION ...
Read moreTORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.